|
| Quotes |
| WORDS FROM THE CCTA EXPERTS |
|
|
- "COR Analyzer™ acts as an imaging assistant. It helps focus your attention quickly to specific areas of greatest concern, and alert you to segments that may have been under-appreciated in terms of stenosis severity. Its value is particularly high in two contexts: the ED where time is of the essence, and for the physician who is relatively new to Coronary CTA, as a learning tool."
-- Jack A. Ziffer, MD, PhD, Director of Cardiac Imaging at the Miami Cardiac and Vascular Institute and Medical Director of Nuclear Medicine at the Baptist Medical Center of Miami.
- "Coronary Computed Tomography Angiography has emerged as the most accurate non-invasive imaging test for diagnosing significant coronary artery disease in patients with low to intermediate risk of having coronary artery disease. COR Analyzer™ is an innovative approach to the meet the increasing demand on the radiologists and cardiologists to rapidly exclude coronary artery disease as a cause of acute chest pain in the emergency department."
-- Michael Poon, MD, Professor of Radiology at Stony Brook School of Medicine, State University of New York and Director of Cardiac Computed Tomography Imaging and MDCT Core Laboratory at the Cardiovascular Research Foundation
|
|
|
| Company Profile |
|
|
Rcadia Medical Imaging is the principal developer and distributor of automatic image processing software products for blood vessel analysis. The company's FDA cleared COR Analyzer™ performs analysis of Coronary CT angiography (“CCTA”) studies and automatically, without human intervention, identifies severe lesions in the main coronary arteries.
COR Analyzer™ is aimed at triaging patients in the ED, improve workflow in radiology and cardiology departments, and serves as ‘second glance reader’ to prevent missing lesions in CCTA studies. |
|
|
| Press News |
| READ WHAT WE HAVE BEEN DOING LATELY |
|
|
|
|
|
|
|
|
